Frontlight ResearchEarly access
Antiphospholipid syndrome trials in France
12 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 17 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peoplePhase IB open label, long-term, extension basket trial of RAY121 to inhibit classical complement pathway in immunological diseases (RAINBOW-LTE trial)
- Where
- Montpellier Cedex 5, Paris
- Age
- 18 years and over
- People
- 78 worldwide
- Run by
- Chugai Pharmaceutical Co. Ltd.
See details and how to join2024-511346-39-00 - No phaseTaking peopleFollow-up Cohort of Patients With Antiphospholipid Syndrome
- Where
- Rouen
- Age
- 18 years to 75 years
- People
- 200
- Run by
- University Hospital, Rouen
See details and how to joinNCT07178925 - Phase 3Not yet taking people in FranceAnticoagulant Cessation After Antiphospholipid Autoantibodies Loss in Thrombotic Antiphospholipid Syndrome
- Where
- Paris
- Age
- 18 years and over
- People
- 234
- Run by
- Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT07875153 · EU 2026-526448-12-00 - No phaseTaking peopleCharacterization of Autoreactive b Lymphocytes in Autoimmune Diseases and Immune Deficiencies
- Where
- Strasbourg
- Age
- 18 years to 70 years
- People
- 200
- Run by
- University Hospital, Strasbourg, France
See details and how to joinNCT07251179 - Phase 1Active, not recruitingPhase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
- Where
- Montpellier Cedex 5, Paris Cedex 13
- Age
- 18 years to 85 years
- People
- 144 worldwide
- Run by
- Chugai Pharmaceutical
See details and how to joinNCT06371417 · EU 2023-507692-21-00 - Phase 1Enrolling by invitationPhase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial)
- Where
- Montpellier, Paris
- Age
- 18 years to 85 years
- People
- 144 worldwide
- Run by
- Chugai Pharmaceutical
See details and how to joinNCT06723106 - No phaseTaking peopleInternational Registry of Thrombotic APS Patients Treated With Direct Oral Anticoagulants
- Where
- Nancy
- People
- 500
- Run by
- Stéphane Zuily
See details and how to joinNCT04262492 - No phaseNot yet taking people in FrancePoint of Care Testing INR in Antiphospholipid Syndrome
- Where
- Vandœuvre-lès-Nancy
- Age
- 18 years and over
- People
- 150
- Run by
- Central Hospital, Nancy, France
See details and how to joinNCT07570511 - No phaseTaking peoplePrevalence and Consequences of Antiphospholipid Syndrome in Patients Aged 65 and Over With Ischemic Strokes (IS)
- Where
- Reims
- Age
- 65 years and over
- People
- 400
- Run by
- CHU de Reims
See details and how to joinNCT07163338 - No phaseTaking peopleEvaluation of Cell Membrane Expression of Annexin A2 on Monocytes by Flow Cytometry in Primary Antiphospholipid Syndrome
- Where
- Amiens
- Age
- 18 years and over
- People
- 60
- Run by
- Centre Hospitalier Universitaire, Amiens
See details and how to joinNCT06373926 - No phaseNot yet taking people in FranceDOAC Versus VKA in Patients With Non-high-risk APS : Prospective Cohort Study
- Where
- Amiens, Besançon, Brest, Dijon, Lyon, Metz, Mulhouse, Nantes, Paris, Reims, Saint-Priest-en-Jarez, Strasbourg, Vandœuvre-lès-Nancy
- Age
- 18 years and over
- People
- 310
- Run by
- Central Hospital, Nancy, France
See details and how to joinNCT06884384 - No phaseTaking peopleLaboratory and Clinical Data in Antiphospholipid Patients
- Where
- Lille, Nancy
- Age
- 18 years and over
- People
- 60
- Run by
- Central Hospital, Nancy, France
See details and how to joinNCT04308564